| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |